JULY 2026
FDA Proposes New Pathway for Diagnostics — CPPC Response
The U.S. Food and Drug Administration (FDA) has proposed a new regulatory pathway for laboratory-developed tests (LDTs) that could ...
NEWS & UPDATES
Stay current with CPPC's latest activity, from policy statements and state engagement to media mentions and coalition milestones.
JULY 2026
The U.S. Food and Drug Administration (FDA) has proposed a new regulatory pathway for laboratory-developed tests (LDTs) that could ...
JULY 2026
Federal healthcare policy continues to evolve as lawmakers, regulatory agencies, and healthcare organizations work to address the changing ...
JULY 2026
The Coalition to Protect Patient Care (CPPC) has submitted formal comments regarding the Food and Drug Administration's proposed regulatory ...
No updates match your search.
FEATURED
Statements
The U.S. Food and Drug Administration (FDA) has proposed a new regulatory pathway for laboratory-developed tests (LDTs) that could significantly change how diagnostic tests are reviewed before reaching patients. The ...
The U.S. Food and Drug Administration (FDA) has proposed a new regulatory pathway for laboratory-developed tests (LDTs) that could significantly change how ...
Read more →
Federal healthcare policy continues to evolve as lawmakers, regulatory agencies, and healthcare organizations work to address the changing needs of patients across ...
Read more →
The Coalition to Protect Patient Care (CPPC) has submitted formal comments regarding the Food and Drug Administration's proposed regulatory pathway for diagnostic ...
Read more →
As healthcare policy discussions continue to evolve across the country, the Coalition to Protect Patient Care (CPPC) has expanded its advocacy efforts into five ...
Read more →No posts found in this category.
Free PDF. Just your name and email and we'll send it to you instantly. No spam, no login, no hassle.